Inhibition of indoleamine dioxygenase leads to better control of tuberculosis adjunctive to chemotherapy.

Singh, Bindu; Moodley, Chivonne; Singh, Dhiraj K; Escobedo, Ruby A; Sharan, Riti; Arora, Garima; Ganatra, Shashank R; Shivanna, Vinay; Gonzalez, Olga; Hall-Ursone, Shannan; Dick, Edward J; Kaushal, Deepak; Alvarez, Xavier; Mehra, Smriti

Singh, Bindu; Moodley, Chivonne; Singh, Dhiraj K; Escobedo, Ruby A; Sharan, Riti; Arora, Garima; Ganatra, Shashank R; Shivanna, Vinay; Gonzalez, Olga; Hall-Ursone, Shannan; Dick, Edward J; Kaushal, Deepak; Alvarez, Xavier; Mehra, Smriti.

JCI Insight ; 8(2)2023 Jan 24.

Article em En | MEDLINE | ID: mdl-36692017

Assuntos

Mycobacterium tuberculosis; Tuberculose Pulmonar; Tuberculose; Animais; Humanos; Granuloma; Indolamina-Pirrol 2,3,-Dioxigenase; Macrófagos/metabolismo; Mycobacterium tuberculosis/metabolismo

Palavras-chave

Antigen presentation; Immunology; Infectious disease

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar / Mycobacterium tuberculosis Limite: Animals / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google